Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-12,411
Closed -$2.01M 21
2015
Q4
$2.01M Sell
12,411
-1,932
-13% -$304K 0.33% 115
2015
Q3
$1.98M Buy
+14,343
New +$2.26M 0.26% 162
2015
Q1
Sell
-7,485
Closed -$1.19M 495
2014
Q4
$1.19M Sell
7,485
-2,567
-26% -$400K 0.15% 266
2014
Q3
$1.41M Sell
10,052
-2,512
-20% -$328K 0.22% 195
2014
Q2
$1.49M Buy
+12,564
New +$1.45M 0.22% 185
2014
Q1
Sell
-10,163
Closed -$1.16M 462
2013
Q4
$1.16M Sell
10,163
-4,923
-33% -$560K 0.19% 216
2013
Q3
$1.69M Buy
15,086
+9,025
+149% +$979K 0.32% 131
2013
Q2
$598K Buy
+6,061
New +$629K 0.12% 278

Other funds holding AMGN

Santa Fe Partners's AMGN Position: Q1 2016 in Review

Santa Fe Partners sold out of Amgen (AMGN) in Q1 2016, closing a stake of 12,411 shares — an estimated $2.01M sold.

Santa Fe Partners first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $2.01M in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Santa Fe Partners reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 12,411 Amgen shares in Q1 2016, an estimated $2.01M.
  • Santa Fe Partners first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Santa Fe Partners's Amgen position peaked at $2.01M in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.